Silexion Therapeutics Corp

US$0.15As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SLXNHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (87.33%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.29)
PE TTM —
TSR TTM (99.56%)
Mkt cap US$0.807M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.174
19.69%
(15.73%)
Buy 7|0|8|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
29.79%
42.21%
24.88%
23.53%
Revenue$M
0.046
0.049
0.050
0.049
16.10%
17.92%
17.39%
10.92%
Peers (US$0.807M)
Cap (US$)
PE
1.580M
—
0.243M
—
Capital
TTM
5Y
10Y
Leveragex
0.136
(0.056)
(0.052)
EBIT/Intx
0.460
0.320
0.238
Own earn%
73.67
47.70
56.68
Sh yield%
53.46
30.03
31.75
Owners
Insiders/Inst%
6.43
48.42
Short interest%
5.71
SBC / revenue%
2.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
32–41
$1 testx
0.0
Incr. ROIC%
12